Double-Blind Evaluation of Maintenance of Efficacy of Pramipexole Extended-Release in Early Parkinson's Disease

被引：0
|
作者：
Salin, Laurence
Hauser, Robert
Koester, Juergen
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A319
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy and Safety of Pramipexole Extended-Release in Advanced Parkinson's Disease: An Open-Label Trial
    Schapira, Anthony
    Barone, Paolo
    Hauser, Robert
    Mizuno, Youshikuni
    Rascol, Olivier
    Busse, Michael
    Salin, Laurence
    Sohr, Mandy
    Poewe, Werner
    NEUROLOGY, 2010, 74 (09) : A349 - A350
  • [32] Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
    Mizuno, Y
    Yanagisawa, N
    Kuno, S
    Yamamoto, M
    Hasegawa, K
    Origasa, H
    Kowa, H
    MOVEMENT DISORDERS, 2003, 18 (10) : 1149 - 1156
  • [33] Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
    Guttman, M
    Ott, E
    Tragner, H
    Bedard, PJ
    Pourcher, E
    Curran, T
    Goodridge, A
    Guttman, M
    Hobson, D
    King, D
    Martin, WRW
    Mendis, T
    Rajput, A
    Rivest, J
    Stoessl, J
    Suchowersky, O
    Moran, J
    Murphy, R
    Walsh, B
    ONeill, DO
    Klemperer, B
    Martin, M
    Oehlwein, C
    Polzer, U
    Reichmann, H
    Schimek, J
    Schlenker, M
    Schwartz, A
    Meier, D
    Traubner, P
    Benetin, J
    Bomhof, MAM
    Hovestadt, A
    Vreeling, FW
    Wolters, ECMJ
    Broddie, HG
    Clarke, C
    Clough, CJ
    Loizou, L
    Newman, PK
    Pye, IF
    NEUROLOGY, 1997, 49 (04) : 1060 - 1065
  • [34] Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
    Poewe, Werner H.
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang H.
    Martignoni, Emilia
    Rupp, Markus
    Boroojerdi, Babak
    LANCET NEUROLOGY, 2007, 6 (06): : 513 - 520
  • [35] Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage
    Rascol, O.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Schapira, A.
    Debieuvre, C.
    Sohr, M.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S131 - S132
  • [36] Effects on timing adherence of overnight switching from immediate to extended-release pramipexole in Parkinson's disease
    Iijima, M.
    Osawa, M.
    Maruyama, K.
    Uchiyama, S.
    MOVEMENT DISORDERS, 2014, 29 : S244 - S244
  • [37] BUDGET IMPACT ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    VALUE IN HEALTH, 2015, 18 (07) : A752 - A753
  • [38] Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
    Hametner, Eva-Maria
    Seppi, Klaus
    Poewe, Werner
    CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 83 - 88
  • [39] Pramipexole and its Extended Release Formulation for Parkinson's Disease
    Fishman, Paul S.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 169 - 178
  • [40] Overnight Conversion from Immediate-Release to Extended-Release Pramipexole for Adjunctive Treatment of Advanced Parkinson's Disease
    Schapira, Anthony
    Barone, Paolo
    Hauser, Robert
    Mizuno, Youshikuni
    Poewe, Werner
    Rascol, Olivier
    Busse, Michael
    Salin, Laurence
    Sohr, Mandy
    NEUROLOGY, 2010, 74 (09) : A317 - A317
12345